Showing results (221-230 of 994) with videos related to
Sort By:
Pageof 100
Journal of Pharmaceutical Policy and Practice|July 18, 2023
The association between drug pricing and drug shortage in Saudi Arabia: a retrospective database analysisMohammad A Alowairdhi, Fatimah H Alhussain, Maha I Alomran, et al.Journal of Pharmaceutical Policy and Practice|June 26, 2023
Maximizing the benefits of using biosimilars in EgyptAhmad Nader Fasseeh, Baher Elezbawy, Kareem Ahmed El-Fass, et al.Journal of Pharmaceutical Policy and Practice|July 31, 2023
The specialized competency framework for industry pharmacists (SCF-IP): validation and pilot assessmentHala Sacre, May Saab, Chadia Haddad, et al.Journal of Pharmaceutical Policy and Practice|June 19, 2023
Equipping pharmacists for delivering pharmaceutical care to seniors: a qualitative systematic review of Asian seniors' social supportNiken Nur Widyakusuma, Sri Suryawati, Chairun Wiedyaningsih, et al.Journal of Pharmaceutical Policy and Practice|June 21, 2023
The specialized competency framework for community pharmacists (SCF-CP) in Lebanon: validation and evaluation of the revised versionFouad Sakr, Marwan Akel, Hala Sacre, et al.Journal of Pharmaceutical Policy and Practice|June 14, 2023
From promise to practice: a guide to developing pooled procurement mechanisms for medicines and vaccinesKoray Parmaksiz, Roland Bal, Hester van de Bovenkamp, et al.Journal of Pharmaceutical Policy and Practice|April 3, 2026
Nationwide trends in psychiatric prescription practices for drugs with putative cognitive adverse effects in schizophrenia spectrum and bipolar disorders from 2013 to 2022Nathan Vidal, Solène Frileux, Nadia Younès, et al.Journal of Pharmaceutical Policy and Practice|April 2, 2026
From supply to strategy: leveraging central medical stores experiences and information for health system strengtheningMaria-Belen Tarrafeta-Sayas, Christophe Rerat, Sophie Pilon, et al.Journal of Pharmaceutical Policy and Practice|April 1, 2026
Public contributions to the development of antibiotics: two successful and two failed investmentsLouise Schmidt, Ozren Sehic, Ursula Theuretzbacher, et al.Journal of Pharmaceutical Policy and Practice|May 7, 2021
Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?Hadi A Almansour, Nouf M Aloudah, Tariq M Alhawassi, et al.Pageof 100